Personal information

Activities

Collapse all

Employment (3)

The University of Queensland Diamantina Institute: Woolloongabba, QLD, AU

2022-08-29 to present
Employment
Source: Self-asserted source
Andrew Burgess

ANZAC Research Institute: Concord, NSW, AU

2017-10 to present | Group Leader - Cell Division Lab
Employment
Source: Self-asserted source
Andrew Burgess

Garvan Institute of Medical Research: Darlinghurst, NSW, AU

2012-02-01 to 2017-10 | Lab Head (Cancer)
Employment
Source: Self-asserted source
Andrew Burgess

Education and qualifications (1)

University of Queensland: Brisbane, AU

2000-02-01 to 2014-07-04 | PhD (Centre for Immunology and Cancer Research)
Education
Source: Self-asserted source
Andrew Burgess

Funding (4)

Targeting MASTL kinase, a novel driver of Metastasis in Triple Negative Breast Cancer

2020-12 to 2021-12 | Grant
Tour de cure (Sydney, AU)
GRANT_NUMBER:

RSP-00230-19/20
Source: Self-asserted source
Andrew Burgess

Targeting MASTL kinase, a novel breast cancer oncogene

2018-04 to 2021-04 | Grant
National Breast Cancer Foundation (NSW, NSW, AU)
GRANT_NUMBER:

IIRS-18-103
Source: Self-asserted source
Andrew Burgess

Targeting novel G2 and mitotic checkpoint pathways to improve current chemotherapies.

2012-01 to 2017-01 | Salary award
Cancer Institute NSW (NSW, NSW, AU)
GRANT_NUMBER:

10/FRL/3-02
Source: Self-asserted source
Andrew Burgess

Characterisation of the Chfr mediated mitotic checkpoint arrest.

2005-01-01 to 2008-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 351675
GRANT_NUMBER: 351675
Source: Self-asserted source
Andrew Burgess via DimensionsWizard
How many people are using ORCID?